Financial statements Green Pharma
Balance sheet data of GREEN PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 3 192,11 | 3 200,02 | 370 045,03 | 369 017,37 | 233 975,85 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 9 171,00 | 9 171,00 |
| B. Current assets | 3 192,11 | 3 200,02 | 199 483,14 | 359 846,37 | 224 804,85 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | 0,00 |
| Total liabilities | 3 192,11 | 3 200,02 | 370 045,03 | 369 017,37 | 233 975,85 |
| A. Equity | 1 455,11 | 1 466,02 | -7 937,16 | -19 177,13 | -17 765,52 |
| B. Liabilities and provisions for liabilities | 1 737,00 | 1 734,00 | 377 982,19 | 388 194,50 | 251 741,37 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.